048260 — OsstemImplant Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩3tn
- KR₩3tn
- KR₩1tn
- 98
- 29
- 100
- 92
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 460,147 | 565,043 | 631,596 | 824,566 | 1,053,472 |
Cost of Revenue | |||||
Gross Profit | 258,547 | 319,137 | 378,199 | 496,324 | 670,488 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 431,659 | 524,278 | 534,956 | 683,962 | 820,694 |
Operating Profit | 28,488 | 40,765 | 96,640 | 140,603 | 232,778 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18,024 | 29,330 | 103,059 | 34,988 | 202,238 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6,256 | -21,960 | 103,534 | 23,411 | 144,201 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 12,691 | -16,262 | 107,046 | 25,012 | 138,137 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 12,691 | -16,262 | 107,046 | 25,012 | 138,137 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10,255 | -10,926 | 75,193 | 16,198 | 94,282 |
Dividends per Share |